1. Home
  2. INSE vs ELTX Comparison

INSE vs ELTX Comparison

Compare INSE & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inspired Entertainment Inc.

INSE

Inspired Entertainment Inc.

HOLD

Current Price

$6.63

Market Cap

175.3M

Sector

Technology

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

BUY

Current Price

$3.17

Market Cap

185.4M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
INSE
ELTX
Founded
2002
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
175.3M
185.4M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
INSE
ELTX
Price
$6.63
$3.17
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$14.00
$18.00
AVG Volume (30 Days)
111.8K
428.2K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.29
EPS
N/A
N/A
Revenue
$199,800,000.00
$2,301,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.26
N/A
P/E Ratio
N/A
N/A
Revenue Growth
30.25
N/A
52 Week Low
$6.11
$2.66
52 Week High
$9.95
$16.00

Technical Indicators

Market Signals
Indicator
INSE
ELTX
Relative Strength Index (RSI) 39.76 40.29
Support Level $6.24 $2.72
Resistance Level $8.42 $5.38
Average True Range (ATR) 0.31 0.20
MACD 0.03 0.23
Stochastic Oscillator 25.84 75.00

Price Performance

Historical Comparison
INSE
ELTX

About INSE Inspired Entertainment Inc.

Inspired Entertainment Inc is a gaming technology company, supplying content, platform and other products and services to licensed online and land-based lottery, betting and gaming operators of various countries through a range of distribution channels, on a business-to-business basis. The company provides digital gaming solutions (i) on its own proprietary and secure network, which accommodates a wide range of devices, including land-based gaming machine terminals, mobile devices and online computer applications, and (ii) through third party networks. It operates in four business segments: Gaming, Virtual Sports, Interactive and Leisure. The majority of revenue is derived from the Leisure Segment, which includes the supply of the gaming and amusement machines.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: